93 related articles for article (PubMed ID: 27987634)
21. A Vision "Bolt-On" Item Could Increase the Discriminatory Power of the EQ-5D Index Score.
Luo N; Wang X; Ang M; Finkelstein EA; Aung T; Wong TY; Lamoureux E
Value Health; 2015 Dec; 18(8):1037-42. PubMed ID: 26686788
[TBL] [Abstract][Full Text] [Related]
22. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
23. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
24. General population reference values for the French version of the EuroQol EQ-5D health utility instrument.
Perneger TV; Combescure C; Courvoisier DS
Value Health; 2010 Aug; 13(5):631-5. PubMed ID: 20412541
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in patients surviving non-small cell lung cancer.
Grutters JP; Joore MA; Wiegman EM; Langendijk JA; de Ruysscher D; Hochstenbag M; Botterweck A; Lambin P; Pijls-Johannesma M
Thorax; 2010 Oct; 65(10):903-7. PubMed ID: 20861294
[TBL] [Abstract][Full Text] [Related]
26. Italian population-based values of EQ-5D health states.
Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
[TBL] [Abstract][Full Text] [Related]
27. Assessing DIF among small samples with separate calibration t and Mantel-Haenszel χ² statistics in the Rasch model.
Bernstein I; Samuels E; Woo A; Hagge SL
J Appl Meas; 2013; 14(4):389-99. PubMed ID: 24064579
[TBL] [Abstract][Full Text] [Related]
28. Testing whether patients with diabetes and healthy people perceive the meaning of the items in the Persian version of the SF-36 questionnaire similarly: a differential item functioning analysis.
Bagheri Z; Jafari P; Mahmoodi M; Dabbaghmanesh MH
Qual Life Res; 2017 Apr; 26(4):835-845. PubMed ID: 27699556
[TBL] [Abstract][Full Text] [Related]
29. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
[TBL] [Abstract][Full Text] [Related]
30. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.
Swinburn P; Lloyd A; Boye KS; Edson-Heredia E; Bowman L; Janssen B
Value Health; 2013 Dec; 16(8):1156-62. PubMed ID: 24326169
[TBL] [Abstract][Full Text] [Related]
31. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
[TBL] [Abstract][Full Text] [Related]
32. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
Günther OH; Roick C; Angermeyer MC; König HH
J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
[TBL] [Abstract][Full Text] [Related]
33. Rasch Analysis of the Dermatology Life Quality Index Reveals Limited Application to Chinese Patients with Skin Disease.
He Z; Lo Martire R; Lu C; Liu H; Ma L; Huang Y; Li Y; Sun L; Bai Y; Liu W; Zha X
Acta Derm Venereol; 2018 Jan; 98(1):59-64. PubMed ID: 28676885
[TBL] [Abstract][Full Text] [Related]
34. Convergent validity and responsiveness of the EQ-5D utility weights for stroke survivors.
Lu WS; Huang SL; Yang JF; Chen MH; Hsieh CL; Chou CY
J Rehabil Med; 2016 Apr; 48(4):346-51. PubMed ID: 26998880
[TBL] [Abstract][Full Text] [Related]
35. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
Kay S; Ferreira A
Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
[TBL] [Abstract][Full Text] [Related]
36. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
[TBL] [Abstract][Full Text] [Related]
37. EQ-5D-3L derived population norms for health related quality of life in Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
PLoS One; 2014; 9(11):e108434. PubMed ID: 25365171
[TBL] [Abstract][Full Text] [Related]
38. Performance of the EQ-5D in patients with irritable bowel syndrome.
Bushnell DM; Martin ML; Ricci JF; Bracco A
Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
[TBL] [Abstract][Full Text] [Related]
39. EQ-5D Scores for Diabetes-Related Comorbidities.
Sullivan PW; Ghushchyan VH
Value Health; 2016 Dec; 19(8):1002-1008. PubMed ID: 27987626
[TBL] [Abstract][Full Text] [Related]
40. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
